03/22/2024
10:12 AM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form DEFA14A | |
03/22/2024
10:08 AM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form ARS | |
03/21/2024
4:25 PM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form DEF 14A | |
03/21/2024
4:27 PM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form DEFA14A | |
03/11/2024
3:30 PM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form PRE 14A | |
03/11/2024
3:15 PM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/23/2024
7:30 AM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
|
12/18/2023
9:04 AM | MILBY RANDY (Reporting)
Hillstream BioPharma (Issuer)
Tharimmune, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2023
3:15 PM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/11/2023
5:15 AM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form 8-K/A | |
12/08/2023
6:31 AM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/06/2023
7:13 PM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/04/2023
3:15 PM | MILBY RANDY (Reporting)
Hillstream BioPharma (Issuer)
Tharimmune, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2023
11:15 PM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form EFFECT | |
11/17/2023
4:24 PM | Hillstream BioPharma (Subject)
Tharimmune, Inc. (Subject)
| Form FWP | |
11/09/2023
6:51 PM | Anderson Kelly (Reporting)
Hillstream BioPharma (Issuer)
Tharimmune, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/09/2023
6:52 PM | Appajosyula Sireesh (Reporting)
Hillstream BioPharma (Issuer)
Tharimmune, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/09/2023
6:55 PM | Bui Lynne A. (Reporting)
Hillstream BioPharma (Issuer)
Tharimmune, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/09/2023
6:48 PM | Mazur Leonard L (Reporting)
Hillstream BioPharma (Issuer)
Tharimmune, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/07/2023
4:02 PM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/07/2023
11:29 AM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form DEL AM | |
11/06/2023
4:12 PM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
10/24/2023
3:15 PM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/29/2023
3:05 PM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form DEFA14A | |
09/25/2023
3:15 PM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/12/2023
7:30 AM | Hillstream BioPharma (Filer)
Hillstream BioPharma Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/30/2023
4:22 PM | Hillstream BioPharma (Filer)
Hillstream BioPharma Inc. (Filer)
| Form DEFA14A | |
08/30/2023
4:20 PM | Hillstream BioPharma (Filer)
Hillstream BioPharma Inc. (Filer)
| Form DEF 14A | |
08/18/2023
4:15 PM | Hillstream BioPharma (Filer)
Hillstream BioPharma Inc. (Filer)
| Form PRE 14A | |
07/17/2023
3:15 PM | Hillstream BioPharma (Filer)
Hillstream BioPharma Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/11/2023
4:25 PM | Hillstream BioPharma (Filer)
Hillstream BioPharma Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/20/2023
3:54 PM | Hillstream BioPharma (Filer)
Hillstream BioPharma Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/27/2023
4:06 PM | Hillstream BioPharma (Subject)
Hillstream BioPharma Inc. (Subject)
| Form FWP | |
